Percutaneous Therapies for Hepatocellular Carcinoma: Evolution of Liver Directed Therapies

Timothy C Huber, Teodora Bochnakova, Yilun Koethe, Brian Park, Khashayar Farsad
2021 Journal of Hepatocellular Carcinoma  
Percutaneous ablation is a mainstay of treatment for early stage, unresectable hepatocellular carcinoma (HCC). Recent advances in technology have created multiple ablative modalities for treatment of this common malignancy. The purpose of this review is to familiarize readers with the technical and clinical aspects of both existing and emerging percutaneous treatment options for HCC.
doi:10.2147/jhc.s268300 pmid:34589446 pmcid:PMC8476177 fatcat:ngwqo4mvvbewpeiwxvhyg3irmi